Tyra Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tyra Biosciences generated cash of -$50,139,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,537,000 last year. Net change in cash is therefore -$193,207,000.
Cash Flow
| 2019 | -2.61M | -20K | 157K |
|---|---|---|---|
| 2020 | -7.76M | -312K | 23.43M |
| 2021 | -23.74M | -645K | 311.34M |
| 2022 | -50.28M | -559K | 632 |
| 2023 | -50.13M | -144.60M | 1.53M |
TYRA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 252.21M | 302.42M | 15.46M | 108K | 2.58M |
Operating activities | |||||
Net income | -69.13M | -55.32M | -26.29M | -9.33M | -4.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 353K | 296K | 140K | 47K | 8K |
Stock-based compensation expense | 13.52M | 10.58M | 2.88M | 439K | 0 |
| Deferred income tax benefit | 13.52M | 10.58M | 2.88M | 439K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 9.36M | 2.35M | 1.49M | 1.01M | 461K |
Cash generated by operating activities | -50.13M | -50.28M | -23.74M | -7.76M | -2.61M |
Investing activities | |||||
Purchases Of Investments | -143.83M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -770K | -559K | -661K | -312K | -20K |
Acquisitions Net | 0 | 0 | 16K | 0 | 0 |
Cash generated by investing activities | -144.60M | -559K | -645K | -312K | -20K |
Financing activities | |||||
Common Stock Issued | 1.53M | 632K | 181.22M | 23.45M | 165K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -9K | -17K | -8K |
Cash used in financing activities | 1.53M | 632 | 311.34M | 23.43M | 157K |
Net Change In Cash | -193.20M | -50.21M | 286.95M | 15.35M | -2.48M |
Cash at end of period | 59.00M | 252.21M | 302.42M | 15.46M | 108K |
| Data source | Data source | Data source |